Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Sell
49
PSCH Quote, Financials, Valuation and Earnings
Last price:
$40.24
Seasonality move
:
3.57%
Day range:
$40.18 - $40.58
52-week range:
$36.69 - $49.05
Dividend yield:
0.24%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
8.1K
Avg. volume:
7.1K
1-year change:
-5.58%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$40.64 | -- | -- | -- | $0.01 | 0.24% | -- |
|
BBH
VanEck Biotech ETF
|
$148.17 | -- | -- | -- | $1.25 | 0.85% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$55.23 | -- | -- | -- | $0.00 | 0% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$36.45 | -- | -- | -- | $0.03 | 0.07% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$28.45 | -- | -- | -- | $1.17 | 4.13% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$79.30 | -- | -- | -- | $0.01 | 0.17% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 1.681 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.014 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.267 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.485 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.374 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.543 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
Invesco S&P SmallCap Health Care ETF vs. Competitors
-
Which has Higher Returns PSCH or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About PSCH or BBH?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is PSCH or BBH More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.993, which suggesting that the stock is 0.736% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.621%.
-
Which is a Better Dividend Stock PSCH or BBH?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.24%. VanEck Biotech ETF offers a yield of 0.85% to investors and pays a quarterly dividend of $1.25 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or BBH?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns PSCH or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About PSCH or BBP?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is PSCH or BBP More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.993, which suggesting that the stock is 0.736% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.610, suggesting its less volatile than the S&P 500 by 38.994%.
-
Which is a Better Dividend Stock PSCH or BBP?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.24%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or BBP?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns PSCH or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About PSCH or PTH?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is PSCH or PTH More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.993, which suggesting that the stock is 0.736% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.925, suggesting its less volatile than the S&P 500 by 7.464%.
-
Which is a Better Dividend Stock PSCH or PTH?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.24%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or PTH?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns PSCH or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About PSCH or SBIO?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is PSCH or SBIO More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.993, which suggesting that the stock is 0.736% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.811, suggesting its less volatile than the S&P 500 by 18.871%.
-
Which is a Better Dividend Stock PSCH or SBIO?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.24%. ALPS Medical Breakthroughs ETF offers a yield of 4.13% to investors and pays a quarterly dividend of $1.17 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or SBIO?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns PSCH or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About PSCH or XBI?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is PSCH or XBI More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.993, which suggesting that the stock is 0.736% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.396%.
-
Which is a Better Dividend Stock PSCH or XBI?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.24%. SPDR S&P Biotech ETF offers a yield of 0.17% to investors and pays a quarterly dividend of $0.01 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or XBI?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 29
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
